|  We innovate for people

Healthcare expenditure

21|4|2016

Monthly Bulletin 126

11:26 Farmaindustria
 
Download document
19|4|2016

Monthly Bulletin 125

14:48 Farmaindustria
 
Download document
23|2|2016

Monthly Bulletin 124

17:50 Farmaindustria
 
Download document
8|1|2016

Monthly Bulletin 123

14:34 Farmaindustria
 
Download document
4|12|2015

Monthly Bulletin 122

12:28 Farmaindustria
 
Download document
3|12|2015

THE PHARMACEUTICAL INDUSTRY AND GLOBAL HEALTH – IFPMA FACTS & FIGURES 2015

10:10 Farmaindustria
 
Download document
4|11|2015

Farmaindustria and the Ministries of Finance and Health sign a Protocol for sustainability, access and innovation

17:45 Farmaindustria
The agreement will have duration of 12-months, with the possibility of it being extended, and will take effect from December 1st
 
4|9|2015

FARMAINDUSTRIA requests that sustainability, access and innovation are not deemed incompatible within the Spanish National Health System

09:55 Farmaindustria
The XV Pharmaceutical Industry Meeting focused on financing innovations this year
 
4|7|2015

Monthly Bulletin 121

12:30 Farmaindustria
 
Download document
16|6|2015

Public pharmaceutical expenditure will grow well below that of the Spanish economy in the forthcoming years

11:58 Farmaindustria
Issue 120 of Farmaindustria’s monthly economic bulletin has been released
 
Notice:

Please be advised that this micro site does not reflect the whole content of Farmaindustria’s main website. Our intention is to offer both the essential information about the Association and updated information regarding the most recent developments affecting Spanish pharmaceutical policies, expenditure and market evolution.

If you can’t find what you are looking for, please send an e-mail to Farmaindustria’s international department, and we will get back to you as soon as we can.

Logo de Pacto Digital para la Protección de las Personas
Logo de Pacto Digital para la Protección de las Personas

© 2024 FarmaIndustria All rights reserved

Recuperar datos
REGISTRARSE